UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

Current Report

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) March 3, 2015

 

 

HOLOGIC, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

 

DELAWARE

(State or Other Jurisdiction of Incorporation)

 

1-36214   04-2902449
(Commission File Number)   (I.R.S. Employer Identification No.)

 

35 Crosby Drive, Bedford, MA   01730
(Address of Principal Executive Offices)   (Zip Code)

(781) 999-7300

(Registrant’s Telephone Number, Including Area Code)

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

Hologic, Inc. (“Hologic” or the “Company”) held its Annual Meeting of Stockholders on March 3, 2015. At the meeting, a total of 261,882,429 shares or 93.59% of the Common Stock issued and outstanding as of the record date were represented in person or by proxy.

The final results for each of the matters submitted to a vote of stockholders at the meeting are set forth below. A more detailed description of each proposal is set forth in the Company’s proxy statement filed with the Securities and Exchange Commission on January 16, 2015.

Proposal No. 1. Election of Directors. The stockholders elected all of the Board of Directors’ nominees for director, to serve until the Company’s next Annual Meeting of Stockholders or until their respective successors are duly elected and qualified, by the votes set forth in the table below:

 

Name

    For      Withheld          Abstained          Broker Non-Vote  

Jonathan Christodoro

      246,762,800         2,017,438         —           13,102,191   

Sally W. Crawford

      215,569,260         33,210,978         —          13,102,191   

Scott T. Garrett

      246,807,770         1,972,468         —          13,102,191   

David R. LaVance, Jr.

      212,318,864         36,461,374         —          13,102,191   

Nancy L. Leaming

      215,346,687         33,433,551         —          13,102,191   

Lawrence M. Levy

      246,706,386         2,073,852         —          13,102,191   

Stephen P. MacMillan

      247,474,728         1,305,510         —          13,102,191   

Samuel Merksamer

      222,802,401         25,977,837         —          13,102,191   

Christiana Stamoulis

      246,521,166         2,259,072         —          13,102,191   

Elaine S. Ullian

      215,663,366         33,116,872         —          13,102,191   

Wayne Wilson

      215,566,573         33,213,665         —           13,102,191   

Proposal No. 2. Advisory Vote to Approve the Company’s Executive Compensation. The stockholders cast an advisory vote to approve executive compensation as set forth in the table below:

 

            For             

            Against                Abstained            Broker Non-Vote    

192,216,077

    56,372,275    191,886    13,102,191

Proposal No. 3. Ratification of Appointment of Independent Registered Public Accounting Firm. The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for fiscal 2015, by the votes set forth in the table below:

 

            For             

            Against                Abstained            Broker Non-Vote    

257,181,222

    4,559,001    142,206    —  

Proposal No. 4. Shareholder Proposal Regarding a Severance Approval Policy. The stockholders cast a vote on a shareholder proposal regarding a severance approval policy as set forth in the table below:

 

            For             

            Against                Abstained            Broker Non-Vote    

135,115,286

    113,498,826    166,126    13,102,191

Proposal No. 5. Shareholder Proposal Regarding Shareholder Input on Poison Pills. The stockholders cast a vote on a shareholder proposal regarding shareholder input on poison pills as set forth in the table below:

 

            For             

            Against                Abstained            Broker Non-Vote    

212,930,919

    35,676,786    172,533    13,102,191

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: March 4, 2015 HOLOGIC, INC.
By:

/s/ Robert W. McMahon

Robert W. McMahon
Chief Financial Officer
Hologic (NASDAQ:HOLX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Hologic Charts.
Hologic (NASDAQ:HOLX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Hologic Charts.